Cargando…

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers

BACKGROUND: Bisphosphonates (BPs) were designed for the prevention of skeletal-related events secondary to bone metastases. The purpose of this study was to show that zoledronic acid (ZA) directly eradicates highly tumorigenic and potentially metastatic cancer cells. MATERIALS AND METHODS: Human pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almubarak, Hussain, Jones, Antonia, Chaisuparat, Risa, Zhang, Ming, Meiller, Timothy F., Scheper, Mark A.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030761/ https://www.ncbi.nlm.nih.gov/pubmed/21297922 http://dx.doi.org/10.4103/1477-3163.75723

Ejemplares similares

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction
Publicado: (2015)

A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis
por: Scheper, MA, et al.
Publicado: (2010)

Bisphosphonate-Associated Osteonecrosis of the Jaw: Are We Dealing with a Localized Non-Traditional Calciphylaxis?
por: Meiller, TF, et al.
Publicado: (2012)

PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells
por: Huang, Wenqiang, et al.
Publicado: (2016)

The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma
por: Zu, Yukun, et al.
Publicado: (2022)

Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
por: Zhang, Junfeng, et al.
Publicado: (2019)

PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
por: Duan, Huijie, et al.
Publicado: (2019)

microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma
por: Fang, Wei, et al.
Publicado: (2017)

Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases
por: Teng, Y, et al.
Publicado: (2010)

miR-17* Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes
por: Xu, Yong, et al.
Publicado: (2010)

Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest
por: An, Yulin, et al.
Publicado: (2021)

Knockdown of TGIF attenuates the proliferation and tumorigenicity of EC109 cells and promotes cisplatin-induced apoptosis
por: Wang, Yadong, et al.
Publicado: (2017)

Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancer
por: Niraula, Saroj, et al.
Publicado: (2017)

Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor
por: Wang, Xi, et al.
Publicado: (2014)

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro
por: Li, Pengfei, et al.
Publicado: (2018)

Tumorigenic potential of circulating prostate tumor cells
por: Carvalho, Filipe LF., et al.
Publicado: (2013)

miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway
por: Xu, Dan-dan, et al.
Publicado: (2016)

ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts
por: Al-Ansari, Mysoon M., et al.
Publicado: (2018)

Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
por: Yang, Hyun Suk, et al.
Publicado: (2016)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
por: Ibrahim, Toni, et al.
Publicado: (2012)

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
por: Jagdev, S P, et al.
Publicado: (2001)

Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells
por: Sheweita, Salah A., et al.
Publicado: (2020)

Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin
por: Xiao, Jialing, et al.
Publicado: (2022)

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019)

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
por: Ubellacker, Jessalyn M., et al.
Publicado: (2017)

Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2015)

Suppression of Tumorigenicity in Breast Cancer Cells by the Microfilament Protein Profilin 1
por: Janke, Jürgen, et al.
Publicado: (2000)

Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells
por: Heino, Terhi J, et al.
Publicado: (2016)

Suppression of tumorigenicity by plakoglobin: an augmenting effect of N- cadherin
Publicado: (1996)

Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells
por: Yang, Xiaoli, et al.
Publicado: (2021)

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
por: Richhariya, Akshara, et al.
Publicado: (2012)

Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells
por: Jiang, Lianggui, et al.
Publicado: (2021)

Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
por: Gao, Si-yong, et al.
Publicado: (2017)

SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
por: Gu, Minghui, et al.
Publicado: (2022)

Sialolipoma of the Lower Lip: Case Report and Literature Review
por: Binmadi, Nada O, et al.
Publicado: (2012)

Metabolomics profiling reveals differences in proliferation between tumorigenic and non-tumorigenic Madin-Darby canine kidney (MDCK) cells
por: Sun, Na, et al.
Publicado: (2023)

Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
por: Hasan, Amal, et al.
Publicado: (2020)

BC047440 antisense eukaryotic expression vectors inhibited HepG(2) cell proliferation and suppressed xenograft tumorigenicity
por: Lu, Zheng, et al.
Publicado: (2012)

Prior administration of vitamin K(2) improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization
por: Zhao, Bin, et al.
Publicado: (2018)

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j30ougjs1s4jj7tl2d4fn3q18n